, and current increase with raising [K ϩ ] o . There was a trend toward larger current densities in myopathic (at Ϫ130 mV in [K ϩ ] o 25 mmol/L; DCM: Ϫ1.37Ϯ0.12 pA/pF, nϭ50; ICM: Ϫ1.39Ϯ0.24 pA/pF, nϭ30) than in nonfailing cells (Ϫ1.18Ϯ0.21 pA/pF, nϭ24), although this difference did not reach statistical significance (Pϭ.23). Boltzmann distributions yielded an activation threshold of Ϫ80 mV and half-maximal activation at Ϫ110.96Ϯ0.06 mV in myopathic and normal myocytes. Isoproterenol (10 Ϫ5 mol/L) shifted the current activation by 10 mV (31 myopathic, 5 NF). Carbachol and adenosine had no direct effect on I f (6 and 12 myopathic, 3 and 3 NF, respectively) but reversibly antagonized ␤-adrenergic stimulation (5 and 7 myopathic, 2 and 2 NF, respectively). Autonomic modulation was similar in failing and nonfailing cells. Conclusions-In end-stage heart failure, no significant change of I f could be found, although there was a trend toward increased I f . Together with an elevated plasma norepinephrine concentration and a previously reported reduction in I K1 in human heart failure, I f might favor diastolic depolarization in individual myopathic cells. (Circulation. 1998;97:55-65.)
Key Words: electrophysiology Ⅲ heart failure Ⅲ ventricles Ⅲ adenosine Ⅲ arrhythmia C ongestive heart failure is a common and highly lethal cardiovascular disorder, with an annual mortality as high as 50%. [1] [2] [3] [4] [5] [6] From 35% to 50% of these death are sudden and unexpected. [7] [8] [9] Most sudden cardiac deaths in heart failure are thought to be caused by ventricular tachyarrhythmias. 10 -14 Although ACE inhibitors were demonstrated to decrease overall mortality in patients with heart failure, the high rate of sudden cardiac death remained almost unchanged despite various therapeutic interventions. [3] [4] [5] Most patients with terminal heart failure have not suffered a previous myocardial infarction. 7 Thus, classic reentry tachycardias around a scar are unlikely to be the main cause of sudden death in these patients.
The evaluation of possible underlying arrhythmogenic mechanisms in severe heart failure has focused mainly on alterations of repolarization. 15 In failing human hearts, a reduction in the transient outward current (I to ) and of the inward rectifier current (I K1 ) have been demonstrated, 16 consistent with an action potential prolongation measured in multicellular and in single-cell recordings. [16] [17] [18] However, spontaneous diastolic depolarizations may also initiate arrhythmias in diseased myocardium.
In sinus node and Purkinje cells, the hyperpolarization-activated inward current (I f ) is considered to contribute significantly to the spontaneous diastolic depolarization phase. 19 -24 I f is a nonselective cation inward current that is blocked by extracellular cesium. [21] [22] [23] [24] [25] I f was found to be stimulated by ␤-adrenoceptor agonists through a shift of the current activation curve to more positive potentials. 21, 22, 25 An I f -like current has also been recorded in ventricular myocytes of mammalian species, such as guinea pigs, 26 dogs, 25, 26 and rats. 27, 28 In spontaneously hypertensive rats, I f density was linearly related to the severity of cardiac hypertrophy and was found to be significantly larger than in undiseased control animals. 28 This led to the hypothesis that overexpression of I f might contribute to the increased propensity of arrhythmias in hypertrophied ventricular myocardium. 28 More recently, we (published in abstract form) 29 and Cerbai et al 30 recorded a hyperpolarization-activated inward current with properties similar to I f in isolated human ventricular myocytes. Our preliminary data suggested an increased I f density in end-stage heart failure compared with cells from undiseased control hearts. 29 Cerbai et al 30 investigated myocytes from three failing hearts but not from nonfailing controls. Therefore, the aim of the present study was to investigate whether I f is overexpressed in ventricular myocytes isolated from hearts of patients with terminal heart failure. Furthermore, the effects of ␤-adrenergic-, muscarinic-, and A 1 -receptor-mediated stimulation, which might additionally increase or decrease I f , have not yet been evaluated in human myocytes. The possible functional relevance of I f for the initiation of arrhythmias in human heart failure is also discussed.
Methods

Patients
Ventricular myocytes were isolated from 34 hearts of patients with end-stage heart failure caused by dilated cardiomyopathy( nϭ23) or ischemic cardiomyopathy (nϭ11) undergoing transplantation. All patients received digoxin and diuretics. No catecholamines or ␤-adrenoceptor blocking drugs were given during 48 hours before transplantation. Informed consent was obtained before organ transplantation. Results were compared with cells prepared from 13 human hearts without heart failure that could not be transplanted for technical reasons (coronary artery disease without myocardial infarction or heart failure [nϭ10], possible systemic infectious disease [nϭ2], and blood group incompatibility [nϭ1]). The isolation procedure was identical in all hearts used.
Cell Isolation
The isolation procedure was described in detail before. 17 A part of the left ventricular wall was excised, together with its arterial branch. The wall segment was then perfused via its arterial branch: 30 minutes with nominally Ca 2ϩ -free modified Tyrode's solution ([mmol/L] NaCl 135, KCl 4, MgCl 2 1, glucose 10, NaH 2 PO 4 0.33, and HEPES 10; pH was adjusted to 7.3 with the addition of NaOH, 37°C), followed by 40 minutes with the same solution with added collagenase (type II, 200 IU/mL; Worthington) and protease (type XIV, 0.3 IU/mL; Sigma Chemical Co). Finally, the enzyme was washed out for 15 minutes with modified Tyrode's solution that contained 100 mol/L Ca 2ϩ . Cells used in this study were taken from the central part of the myocardial wall. Cells were disaggregated by mechanical agitation and, after filtering through a nylon mesh, were stored at room temperature in Tyrode's solution containing 2.0 mmol/L Ca 2ϩ . The living-cell yield was Ϸ5% to 10%. Only cells with clear striation without significant granulation were selected for experiments. In the Tyrode's solution that was used to store cells (containing 4 mmol/L K ϩ , 2 mmol/L Ca 2ϩ ), we observed few cells with slow spontaneous contractions (Ϸ20 to 30 oscillations per minute). By face value, the frequency and number of spontaneously beating myocytes were similar in normal and failing hearts. We were not able to patch spontaneously contracting human ventricular myocytes. Therefore, we did not measure any spontaneously contracting myocytes, although we were investigating the pacemaker current. A total of 133 cells yielded results for these experiments; mean cell capacity was 223.7Ϯ7.3 pF.
Solutions
Cells were superfused with a "standard" Tyrode's solution containing (mmol/L) CaCl 2 2.0, NaCl 115, KCl 25, MgCl 2 ] o 140 mmol/L). A pipette with multiple superfusion lines was positioned over the cell studied to allow fast solution changes. Experiments were performed at a temperature of 22Ϯ0.5°C (unless indicated).
Analog filtering of current recordings was done at 3 kHz. Currents were digitized and stored for off-line analysis (pclamp 6.0, Axon instruments). Cell capacitance was calculated in each cell by applying hyperpolarizing 10-mV steps from a holding potential of Ϫ80 mV and integrating the current required to charge the membrane when stepping back to Ϫ80 mV.
Statistical Analysis
I f size was measured as the difference between the instantaneous current at the beginning of the hyperpolarizing step and the steadystate current at the end of hyperpolarization. 27 Currents were normalized to membrane capacitance to calculate current densities when indicated. Specific conductance of I f was determined for each cell according to the equation gϭI/(V m ϪV rev ), where g is the conductance calculated at the membrane potential V m , I is the current amplitude, and V rev is calculated from the analysis of tail currents. For calculation of steady-state activation curves, specific current conductances were normalized to the maximal current conductance to give g/g max . Boltzmann distributions were fitted to these normalized values:
where V m is the membrane voltage, V 1/2 is the voltage at half-maximal activation, and S is a slope factor at V m ϭV 1/2 . The relative permeabilities of potassium and sodium (P Na/K ) were estimated by fitting the Goldman-Hodgkin-Katz equation 32 to the reversal potential (V rev ): 
Results
Characteristics of I f
Initially, we investigated the basal characteristics of If in human ventricular myocytes. Fig 1A shows a typical original current recording of I f in a single human ventricular myocyte in "standard" Tyrode's solution containing [K ϩ ] o 25 mmol/L. From a holding potential of Ϫ40 mV, a family of hyperpolarization steps in 10-mV increments elicited a time-dependent inward current that increased with more negative potentials. I f could be recorded in all cells investigated (nϭ133). Mean current densities in myopathic cells at Ϫ80 mV and Ϫ130 mV were Ϫ0.15Ϯ0.01 pA/pF and Ϫ1.38Ϯ0.14 pA/pF, respectively (nϭ59). A Boltzmann distribution, which was fitted to normalized current conductances of these 59 cells, showed current activation first at approximately Ϫ80 mV (Fig 1B) . Half-maximal activation and slope factor were Ϫ110.96Ϯ0.06 mV and Ϫ12.26Ϯ0.06 mV
Ϫ1
, respectively (nϭ59). To evaluate, whether there was any significant temperature dependence over a range of 22°C to 37°C, we also investigated 21 myopathic myocytes under similar conditions at a temperature of 37Ϯ0.5°C. At 37Ϯ0.5°C, current densities at Ϫ80 and Ϫ130 mV were not significantly different from results obtained at 22°C. However, consistent with observations in the rabbit sinoatrial node 33 and in sheep Purkinje fibers, 34 current activation was faster at higher temperatures with a Q 10 of 2.28Ϯ0.13.
Similar to mammalian pacemaker cells and ventricular myocytes, the current amplitude increased with increasing external K ϩ concentrations. 21, 22, 27, 35 In [K ϩ ] o 5 mmol/L, current densities at Ϫ80 and Ϫ130 mV were Ϫ0.03Ϯ0.01 and Ϫ0.47Ϯ0.06 pA/pF (nϭ39); in [K ϩ ] o 140 mmol/L, they were Ϫ0.64Ϯ0.15 and Ϫ3.95Ϯ0.57 pA/pF (nϭ16), respectively. Extracellular addition of Cs ϩ 2 mmol/L suppressed the timedependent part of the inward current (nϭ4). Fig 2 depicts original current traces of a single myocyte in "standard" Tyrode's solution before (Fig 2A) and during (Fig 2B) Tail current recordings were used to evaluate the reversal potential (V rev ) of I f . Tail currents, after a hyperpolarizing step to Ϫ120 mV, were elicited by 10-mV steps to 40 to Ϫ40 mV. ; r 2 ϭ.97 for goodness of fit). The relative permeabilities of potassium and sodium (P Na/K ) were estimated by fitting the Goldman-Hodgkin-Katz equation 32 ; r 2 ϭ.98) sections with two separate linear functions, yielding a V rev of Ϫ12.27Ϯ0.30 mV and a P Na/K ratio of 0.53 to 0.56. Because the goodness of fit was not significantly different, we used the simplified single linear approximation for further evaluations.
Effect of ␤-Adrenergic Stimulation
To investigate the effect of ␤-adrenergic stimulation, 36 cells (31 myopathic, 5 nonfailing) were hyperpolarized in "standard" Tyrode's solution before and after the addition of 10 Ϫ5 mol/L isoproterenol. Isoproterenol shifted current activation to more positive potentials without changing the maximal current amplitude and accelerated current activation in myopathic ( Fig 4A) and nonfailing cells. At potentials more positive to Ϫ110 mV, current activation followed a single-exponential function. Time constants at Ϫ100 mV before and after the addition of isoproterenol were 744.7Ϯ17.4 and 703.1Ϯ13.5 months, respectively (nϭ36) (PϭNS). At more negative voltage steps, I f exhibited a sigmoidal time course with an initial delay in activation and was best fitted by a double-exponential function (at Ϫ130 mV: fast , 98.5Ϯ3.5 and 72.4Ϯ2.6 months, PϽ.05; slow , 810Ϯ28 and 824Ϯ29 months in the absence and presence of isoproterenol, respectively; nϭ36). Activation curves before and during isoproterenol application were obtained with hyperpolarizing steps to potentials between Ϫ60 and Ϫ160 mV (Fig 4B) . Activation parameters, calculated by Boltzmann fits of normalized current conductances, showed that isoproterenol 10 Ϫ5 mol/L shifted the potential of halfmaximal activation by 10.30Ϯ0.28 mV (from Ϫ110.42Ϯ0.23 mV to Ϫ100.12Ϯ0.30 mV; nϭ36; PϽ.05) without a significant difference between myopathic (10.17Ϯ0.32 mV; nϭ31) and nonfailing (10.40Ϯ0.48 mV; nϭ5) cells. There was no difference in the current reversal potential in the absence (Ϫ16.1Ϯ0.9 mV) and presence (Ϫ15.2Ϯ0.6 mV) of isoproterenol (nϭ4; PϭNS).
Modulation of I f by Carbachol and Adenosine
In rabbit sinus node cells, I f was found to be directly modulated by acetylcholine and adenosine via muscarinic and A 1 -recep- tors, respectively.
37,38 Therefore, we investigated the effects of carbachol and adenosine on I f in human ventricular myocytes under basal conditions. Cells were first hyperpolarized in standard Tyrode's solution and then in the same solution after the addition of carbachol 10 -4 mol/L or adenosine 10 -5 mol/L and after washout. No direct effect of carbachol (nϭ9; 6 myopathic, 3 controls) or adenosine (nϭ15; 12 myopathic, 3 controls) was observed.
Because I f in human ventricular myocytes was found to be stimulated by isoproterenol, we evaluated the indirect effects of carbachol and adenosine on prestimulated I f . Thus, after hyperpolarization in standard Tyrode's solution, cells were exposed to standard Tyrode's solution containing isoproterenol 10 Ϫ5 mol/L. Then the myocytes were hyperpolarized in the same isoproterenol solution in the presence of carbachol 10 Ϫ4 mol/L or adenosine 10 Ϫ5 mol/L and after washout. Both carbachol and adenosine reversibly antagonized the stimulating ␤-adrenergic shift of current activation. Steady-state activation curves were calculated by Boltzmann distributions, which were fitted to normalized current conductances. Carbachol (10 Ϫ4 mol/L) shifted the potential of half-maximal activation by Ϫ8.44Ϯ0.38 mV from Ϫ101.52Ϯ0.72 to Ϫ109.95Ϯ0.34 mV (nϭ7; 5 myopathic, 2 controls; PϽ.05) (not shown). Half-maximal activation before isoproterenol stimulation (Ϫ110.20Ϯ0.48 mV) and during carbachol exposure was not significantly different. There was no difference in response to carbachol in myopathic and control cells. The current reversal potential was unchanged before (Ϫ15.8Ϯ0.4 mV) and during (Ϫ15.3Ϯ0.8 mV) carbachol application (nϭ3; PϭNS).
After isoproterenol prestimulation, adenosine was also found to reversibly shift current activation to more negative potentials (Fig 5A) . From Fig 5A, it is also evident that adenosine antagonized acceleration of current activation by isoproterenol. Fig 5B shows activation curves obtained by Boltzmann fits of 9 myocytes (7 myopathic, 2 controls) in standard Tyrode's solution without and with added isoproterenol (10 Ϫ5 mol/L) alone and with added isoproterenol plus adenosine (10 Ϫ5 mol/L). Adenosine shifted the (prestimulated) potential of half-maximal activation from Ϫ100.74Ϯ0.59 to Ϫ107.22Ϯ0.33 mV (nϭ9; PϽ.05). Thus, adenosine did not completely reverse the stimulating effect of isoproterenol, although the difference in half-maximal activation in standard Tyrode's solution (Ϫ109.13Ϯ0.43 mV) and in the presence of adenosine was not significantly different. No difference in response to adenosine was obtained between myopathic and nonfailing cells. The reversal potential was similar before (Ϫ15.5Ϯ0.6 mV) and during (Ϫ15.2Ϯ0.4 mV) exposure to adenosine (nϭ5; PϭNS).
The dose dependence of the adenosine effects was examined by exposing cells to adenosine concentrations of 0.1 (nϭ3), 0.3 (nϭ4), 1 (nϭ3), 3 (nϭ7), 10 (nϭ9), 30 (nϭ5) and 100 (nϭ2) mol/L. The adenosine effect was measured as the shift of the activation curve. 
I f in Patients With Heart Failure Versus Undiseased Controls
To evaluate whether there was any overexpression of I f in human heart failure, normalized current densities (at Ϫ130 mV) measured in cells from patients with heart failure were compared with cells from donor hearts. Average current densities in myocytes from patients with dilated cardiomyopathy (Ϫ1.37Ϯ0.12 pA/pF; nϭ50) and ischemic cardiomyopathy (Ϫ1.39Ϯ0.24 pA/pF; nϭ30) were larger than in nonfailing controls (Ϫ1.18Ϯ0.21 pA/pF; nϭ24). This observation was also true when current densities were compared at 22°C and 37°C separately. However, because of the variation in current densities, these differences did not reach statistical significance (Pϭ.23). We did not observe any difference of activation threshold between myopathic cells and nonfailing controls.
Because the inward rectifier current (I K1 ) contributes significantly to the stabilization of the resting membrane potential, we investigated myocytes in physiological potassium concentration ([K ϩ ] o 5 mmol/L) in the absence and in the presence of external Ba 2ϩ . Fig 7 depicts original current recordings of a single ventricular myocyte, demonstrating the magnitude of the outward current I K1 at potentials positive to Ϫ80 mV in relation to the inward current (I f ). Mean current densities of the outward current (I K1 ) obtained in 13 myopathic cells at Ϫ70 and Ϫ60 mV were 0.02Ϯ0.07 and 0.29Ϯ0.07 pA/pF, respectively. Mean current density of I f at Ϫ80 mV in the same cells was Ϫ0.03Ϯ0.01 pA/pF (nϭ13).
Discussion
This report describes the presence of a hyperpolarization-activated inward current in human ventricular myocytes. The current typically activates at potentials negative to Ϫ80 mV, is time and voltage dependent, and can be suppressed by the addition of extracellular cesium. Reversal potentials are consistent with a permeability for the monovalent cations Na ϩ and K ϩ . The relative permeability P Na/K was in the same range as in canine ventricular myocytes at comparable ionic concentrations. 25 Thus, this current has properties similar to the pacemaker current I f . 21 frog sinus venosus, 39 AV node, 40 atrium, 35, 41 Purkinje fibers, 22, 42 and mammalian ventricular myocytes of the guinea pig, 26 dog, 25, 26 and rat. 27, 28 In pacemaker cells, I f is believed to be the major current determining the diastolic depolarization phase. 19 -24 In sinoatrial node cells, I f activates at more positive potentials than in Purkinje cells. But in both tissues, activation occurs within the physiological diastolic voltage range. 21, 22, 24 In mammalian ventricular myocytes, results are controversial. In guinea pig and canine ventricular cells, the activation threshold for I f ranged between Ϫ105 and Ϫ140 mV, 25, 26 much more negative than the potassium equilibrum potential (E K ). In rat ventricular myocytes, however, I f first activated at voltages (Ϫ60 mV) overlapping the resting membrane potential range. 27, 28 In hypertrophic ventricular myocardium of the rat, I f density was significantly higher than in control animals. 28 The authors postulated that overexpression of I f in hypertrophied rat myocardium might be an important arrhythmogenic mechanism in these animals. Because electrophysiological alterations like prolongation of the action potential and reduction in I to were found to be similar in animal models of heart failure and in human heart failure, 16 -18,43-45 we especially wanted to determine whether patients with heart failure might also have an overexpression of I f . The existence of I f in human ventricular myocytes has previously been reported only in a limited number of patients in abstract form by our group 29 and as a Brief Rapid Communication by Cerbai et al. 30 However, data concerning the potential pathophysiological role of I f in the failing human heart compared with undiseased myocardium are still lacking. Therefore, we recorded I f in isolated myocytes of patients with terminal heart failure caused by dilated or ischemic cardiomyopathy and compared these results with nonfailing controls. Our preliminary data obtained in a small number of patients suggested a larger current in the failing human heart. 29 The present results obtained in a much larger group of patients supported our previous findings. Cells isolated from hearts of patients with terminal heart failure were found to have larger average current densities than myocytes from undiseased donor hearts. However, this difference did not reach statistical significance because of large current variations. We did not find any difference in activation threshold between myopathic and undiseased myocytes. First current activation and half-maximal activation were observed at approximately Ϫ80 and Ϫ110 mV, respectively. Thus, similar to rats, activation of I f in human ventricular myocytes occurs at voltages near the diastolic membrane potential, and there seems to be at least a tendency toward an increased current size in the failing human heart. However, to estimate the potential functional relevance of I f in human heart failure, autonomic regulation has to be considered. In various mammalian cardiac tissue, I f was found to be increased by ␤-adrenergic stimulation and decreased by muscarinic agonists via a shift in current activation to more positive or negative potentials, respectively. 21, 22, 25, 28, 38, 46 In sinus node preparations, ␤-adrenoceptor agonists increased the slope of phase 4 diastolic depolarization and enhanced automaticity, whereas muscarinic stimulation slowed the pacing rate. 20, 22, 38, 47, 48 In rat ventricular myocytes, isoproterenol 10 Ϫ7 mol/L shifted activation of I f by approximately 10 mV. 28 In dog ventricular cells, the phosphatase inhibitor calyculin A led to a maximal current shift of 30 mV. 25 In human ventricular myocytes, we found a shift in current activation by 10 mV after ␤-adrenergic stimulation with isoproterenol 10 Ϫ5 mol/L. Unlike in rabbit sinus node cells and sheep and rabbit Purkinje cells, 38, 42, 49, 50 the muscarinic agonist carbachol was found to have no direct effect on I f in human ventricular myocardium. However, similar to canine Purkinje fibers, 46, 51 carbachol antagonized the stimulating action of isoproterenol. Thus, muscarinic agonists seem to have a negative feedback function that might protect the cells from I f increase caused by ␤-adrenergic stimulation. However, patients with heart failure are known to have an increased mol/L (ADOϩISO). Adenosine led to a shift in current activation to more negative potentials and slowed activation kinetics but had no effect on maximal current size. B, Normalized current amplitudes under basal conditions in the presence of isoproterenol (10 Ϫ5 mol/L) alone and in the presence of both isoproterenol and adenosine (10 Ϫ5 mol/L) were fitted by Boltzmann distributions (nϭ9). Adenosine led to a shift in half-maximal current activation from Ϫ100.74Ϯ0.59 to Ϫ107.22Ϯ0.33 mV (PϽ.05). Points represent meanϮSEM.
sympathetic and reduced parasympathetic tone. In patients with heart failure, plasma norepinephrine levels are increased. 52, 53 Additionally, a depressed heart rate variability, an indirect measure of higher sympathetic tone, has been observed in these patients. 54 -56 In our experiments, ␤-agonists stimulated I f in myopathic cells despite the known ␤-receptor downregulation in the failing human heart. 57, 58 Therefore, the higher sympathetic tone in patients with heart failure is likely to be of special importance, because it might lead to a shift in I f activation to more positive potentials in vivo and thus to a further current increase.
In addition to the autonomic ␤-sympathomimetic and muscarinic systems, the endogenous nucleoside adenosine plays a physiological role in the modulation of cardiac function. In mammalian and human myocardium, adenosine binds to specific A 1 -receptors. 59 Depending on the species and the type of myocytes, A 1 -receptors are coupled to various ionic channels via G i proteins in a direct way or an indirect, cAMP-dependent way, antagonizing the effects of catecholamines. 59, 60 In rabbit sinoatrial myocytes, Zaza et al 37 found a direct effect of adenosine on basal I f and a direct reduction in the pacing rate. We did not observe any direct modulation of I f by adenosine in human ventricular myocytes. However, similar to the mode of I f inhibition by carbachol, adenosine attenuated the stimulating effect of ␤-agonists in human ventricular myocardium. This mode of adenosine action is consistent with the negative inotropic effect of adenosine in human ventricular myocardium described by Böhm et al. 59 These authors also observed only an indirect negative inotropic effect but no direct action of adenosine. Under physiological conditions, atrial and ventricular myocardial cells release adenosine at concentrations of 0.1 to 1 mol/L. 61, 62 Therefore, adenosine concentrations that showed inhibitory effects on I f in our experiments were in the physiological range. Under pathological conditions, such as ischemia, 63 increased cardiac workload, 64 or heart failure, 65, 66 elevated adenosine concentrations have been measured. However, in our experiments, adenosine did not entirely antagonize the ␤-adrenergic stimulating effect on I f even at high adenosine concentrations (shift by isoproterenol, 10 mV; maximal shift by adenosine, Ϫ7 mV), although this difference was not statistically significant.
Cerbai et al 30 observed first activation of I f in 24 ventricular myocytes of patients with dilated cardiomyopathy at approximately Ϫ55 mV. This difference in current threshold com- pared with our results may partially be due to the liquid junction potential for which their data apparently were not corrected (approximately Ϫ16 mV). 67 Additionally, the higher Ca 2ϩ concentration in the pipette solution that these authors used may have contributed to this difference in I f threshold. Elevation of intracellular Ca 2ϩ from PCa 10 to 7 shifted the I f activation curve by 13 mV in rat sinoatrial node cells, although not by a direct effect on I f channels. 68, 69 In our experiments, intracellular Ca 2ϩ was buffered and Ca 2ϩ transients were abolished (EGTA in the pipette solution, extracellular Cd 2ϩ to block Ca 2ϩ currents, Na ϩ -free pipette solution to block Ca 2ϩ influx through the Na ϩ -Ca 2ϩ exchange system) to investigate pure I f and to avoid any possible influence of altered intracellular Ca 2ϩ handling on current measurements. However, in patients with end-stage heart failure, an increased diastolic [Ca 2ϩ ] i has been described. 17, 18, 70 This alteration in diastolic Ca 2ϩ may further increase I f in vivo in addition to the effects of elevated sympathetic tone.
We were not able to patch any spontaneously contracting cells. Because I f is known to contribute to diastolic depolarizations in pacemaker cells, I f might have been larger in these spontaneously contracting myocytes. This might have led to an underestimation of current size in our experiments. However, by face value, there was no difference in the number of spontaneously beating cells between failing and control hearts. In addition, the frequency of oscillations was slow, and some myocytes showed "waveform" contractions. Thus, we suppose that in a significant proportion of these cells, spontaneous contractions were caused by calcium overload after the isolation procedure rather than by the pacemaker current I f .
In ] o 0.3 mmol/L would be expected to shift I f activation by Ϸ8 mV under our experimental conditions. However, this value has to be compensated for further for the barium-induced dose-and voltage-dependent block of I f . 82 In sinoatrial node cells, external barium (3 to 5 mmol/L) decreased I f amplitude and shifted the midactivation potential to more negative voltages. 82, 83 In discussions of the functional significance of I f in human myocardium, I f also has to be compared with other currents, especially the inward rectifier current (I K1 ). Negative to the potassium equilibrium potential (E K ), the stabilizing effect of I K1 will drive the membrane potential back to normal resting values. However, at voltages positive to E K , the outward current density of I K1 is rather small. Additionally, the density of I K1 is reduced by Ϸ40% in cells from myopathic ventricles compared with undiseased controls. 16, 84 Although in most myocytes I K1 seems to be larger than I f at physiological potentials, the combination of reduced I K1 size and increased I f size in the failing human heart might favor diastolic depolarizations in individual cells.
In conclusion, patients with end-stage heart failure have a trend toward increased I f densities compared with nonfailing control hearts. Additionally, the elevated sympathetic tone and elevated diastolic [Ca 2ϩ ] i might further increase I f in these patients. Together with a reduced current density of I K1 in heart failure, I f might drive the membrane potential toward threshold in individual cells in the failing human heart. However, further studies are necessary to test whether under these conditions I f can lead to spontaneous diastolic depolarizations in vivo.
